Abbott's stock rises on revenue jump despite COVID-19 hit to business [MarketWatch]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: MarketWatch
Shares of Abbott Laboratories gained 1.0% in premarket trading on Thursday after the company beat revenue expectations for the quarter. The company had net earnings of $564 million, or 31 cents per share, in the first quarter of 2020, compared with $672 million, or 38 cents per share, in the same period a year ago. Adjusted earnings per share were 65 cents, against a FactSet consensus of 59 cents. Revenue was $7.7 billion for the quarter, up 2.5% from $7.5 billion in the first quarter of 2019, against a FactSet consensus of $7.4 billion. Sales in its nutrition and medical devices businesses increased, by 6.3% to $1.9 billion in nutrition (driven in part by increased consumer purchases of pediatric nutrition products in advance of shelter-in-place orders in the U.S.) and by 1.4% to $2.9 billion in devices (due to fewer sales of cardiovascular and neuromodulation devices in hospitals where those procedures slowed or were put on hold). Sales of diagnostics fell 0.8% to $1.8 billion as th
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Jim Carter on Colgate-Palmolive Company (CL): ‘A Surprising Downgrade at Wells Fargo' [Yahoo! Finance]Yahoo! Finance
- AI is Redefining the Hepatitis B and C Diagnostics Market, Set to Grow by USD 3.02 Billion from 2024-2028 with Rising Demand for Molecular Diagnostics - Technavio [Yahoo! Finance]Yahoo! Finance
- Abbott Declares 403rd Consecutive Quarterly DividendPR Newswire
- Abbott a new overweight at Piper Sandler; at attractive entry point [Seeking Alpha]Seeking Alpha
- Jim Cramer: Don't let Abbott Labs' litigation overhang keep you out of the stock [CNBC]CNBC
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- 9/4/24 - Form 4
- ABT's page on the SEC website